Hosler, G A <br/><br/>
Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia.  [electronic resource] 

 -  Leukemia  Jul 2000 
 - 1215-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2401814  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Calibration<br/>Cell Cycle<br/>Cyclophosphamide--therapeutic use<br/>Cytarabine--therapeutic use<br/>DNA, Neoplasm--genetics<br/>Doxorubicin--therapeutic use<br/>Drug Evaluation<br/>Etoposide--therapeutic use<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Leukemia-Lymphoma, Adult T-Cell--drug therapy<br/>Methotrexate--therapeutic use<br/>Mice<br/>Mice, SCID<br/>Neoplasm Transplantation<br/>Neoplasm, Residual<br/>Polymerase Chain Reaction<br/>Prognosis<br/>Reference Standards<br/>Risk Assessment<br/>Specific Pathogen-Free Organisms<br/>Survival Analysis<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured--transplantation<br/>Vincristine--therapeutic use